Start - Aprovix

Qvintip − a quick and simple self-sample kit

Qvintip is a quick and simple self-sample kit followed by DNA analysis that detects 13 high-risk strains of HPV. You use the kit in the comfort of your own home, send it into our lab and get the results by return mail. Qvintip is registered with the Swedish Medical Products Agency.

Our vision: to reduce suffering and save lives

"Our vision is to reduce suffering and deaths caused by cervical cancer using HPV home testing".

Aprovix's business concept is to supply healthcare providers with a tailored, cost-effective and reliable self sampling process combined with HPV testing for early detection of pre-stages of Cervix cancer.

Learn more about Aprovix

Qvintip for healthcare providers

A cost-effective turnkey solution for mass HPV testing

Aprovix offers a turnkey solution for health care providers to reach women that haven't participated in smear test programs. If desired, Aprovix can manage the complete administrative process from sending mailshots, sampling kits and reminders, to analyzing samples and mailing results. Aprovix has developed proprietary software to track the whole process.

Learn more

A solution built on a secure foundation

Qvintip has been evaluated in partnership with Uppsala University Hospital. A total of over 9,000 women have been involved in trials, of which over 3,600 used Qvintip. The Nobel Prize in 2008 and a decision to vaccinate girls against HPV has reinforced the understanding that cervical cancer can be prevented if effective health-checks for HPV infection are offered.

Read the proofs

Qvintip Saves Lives

Qvintip can detect high-risk HPV (human papillomavirus) infections before potential cell changes arise and cervical cancer occurs. Early discovery allows women to take preventative measures in time.

Qvintip Gives Peace of Mind

Self-sampling with Qvintip is suitable for women aged 30 or older. HPV testing is especially important for women who haven't participated in smear test programs or those over 60 that are no longer covered by them. These groups are at the greatest risk of cervical cancer. Qvintip gives them peace of mind − if you're HPV negative, you won't be affected by cervical cancer. (We advise against women under 30 doing HPV tests.)